Sign up
Login
Friday 17th November 2017
13:20 Welcome and introduction (D. Betticher, Fribourg)
Open questions in lymphoma and CLL (A. Moccia)
13:30 The new WHO classification: what changes for the clinician? (S. Dirnhofer, Basel)
14:10 Has PET replaced all other imaging in lymphoma? (L. Ceriani, Bellinzona)
14:50 Does radiotherapy still have a role in lymphoma treatment? (T. Illidge, Manchester)
15:30 Coffee Break
16:00 Should all treatments of Hodgkin lymphoma be (PET-)response-adapted? (A. Moccia, Bellinzona)
16:40 Is genetics-based treatment of DLBCL ready to be applied to patients? (U. Novak, Bern)
17:20 Burkitt and lymphoblastic lymphoma: which regimens should we use? (F. Stenner, Basel)
18:00 Adjourn
Saturday 18th November 2017
Open questions in lymphoma and CLL (M. Ghielmini)
08:00 T-cell lymphomas: any progress in the last 20 years? (F. Hitz, St. Gallen)
08:40 Is there a standard treatment for Mantle Cell lymphoma? (U. Mey, Chur)
09:20 CNS lymphoma and CNS prophylaxis: is high-dose chemo the solution? (A. Ferreri, Milano)
10:00 Coffee Break
10:30 Follicular lymphoma: the end of chemotherapy? (M. Ghielmini, Bellinzona)
11:10 Should Marginal Zone lymphomas be treated as follicular lymphomas? (M. Raderer, Vienna)
11:50 CLL: have new drugs made allogeneic transplantation obsolete? (D. Rossi, Bellinzona)
12:30 Wrap up and closure